M34

Develops gene therapies that cross the blood-brain barrier for neurological disease, and nonviral gene vectors for hemophilia A.

See the full company record.

Founders, funding history and recent signals. Free accounts open immediately.

If you want to work here anyway, tell us what you are after and Adam will pass it to the M34 team when there is a real fit.

Checking listed roles…